“Long-Term Improvements Observed in Tralokinumab-Treated Patients With Moderate-to-Severe Atopic Dermatitis: An ECZTEND Interim Analysis”. SKIN The Journal of Cutaneous Medicine 5, no. 6 (November 5, 2021): s59. Accessed April 20, 2026. https://skin.dermsquared.com/skin/article/view/1410.